30 Years of Evidence
Take a moment to explore a selection of publications and conference abstracts from around the globe. Find evidence for a wide range of treatment sites including malignant and benign disease, different fractionation schedules and real-time motion synchronization techniques for the CyberKnife® and Radixact®/ TomoTherapy® platforms. We update new papers on a regular basis. See how health professionals are helping to improve patient outcomes.
Featured Content
PROSTATE cancer
Comprehensive one-day management of prostate cancer patients: PRO-FAST single-fraction ablative, urethral-sparing, HDR-like, robotic SBRT
Date: 2025
Treatment Technique: SBRT
Platform: CyberKnife System
Author: Andrei Fodor et al.
SPINAL CANCER
Efficacy and Safety of Donut-Shaped Circumferential Spine CyberKnife Stereotactic Body Radiotherapy for Metastatic Spine Disease
Date: 2025
Treatment Technique: SBRT
Platform: CyberKnife System
Author: David J Park et al.
BREAST CANCER
Ablative Preoperative Single-Fraction Radiation Dose Escalation Among Patients With Breast Cancer: A Phase 1 Nonrandomized Clinical Trial
Date: 2025
Treatment Technique: SBRT
Platform: CyberKnife System
Author: Asal Rahimi et al.
2332: Increased Iso-toxic Dose to the Target in Oligometastatic Abdominal Lymph Nodes Using CT-guided Online Adaptive SBRT
Lucy A. van Werkhoven et al. | ESTRO | 2025
3605: Higher Disease-free Survival Observed for Complete Response After SBRT in Oligometastatic Gynecologic Tumors
Gaia Parma et al. | ESTRO | 2025
Efficacy and Safety of Donut-Shaped Circumferential Spine CyberKnife Stereotactic Body Radiotherapy for Metastatic Spine Disease
David J. Park et al. | RSS | 2025
Stereotactic Ablative Body Radiotherapy with w Central High Dose using CyberKnife for Metastatic Lung Tumors
Hayashi K, Suzuki O, Shiomi H, Ono H, Setoguchi A, Nakai M, Nakanishi E, Tatekawa S, Ose N, Hirata T, Tamari K, Seo Y, Funaki S, Isohashi F, Shimizu S, Shintani Y, Ogawa K | BMC Cancer | 2023
Clinical Effects of Stereotactic Body Radiation Therapy Targeting the Primary Tumor of Liver-Only Oligometastatic Pancreatic Cancer
Ji X, Zhao Y, He C, Han S, Zhu X, Shen Z, Chen C, Chu X | Front Oncol | 2021
Treatment of Residual, Recurrent, or Metastatic Intracranial Hemangiopericytomas With Stereotactic Radiotherapy Using CyberKnife
Huang L, Bai J, Zhang Y, Cui Z, Zhang Z, Li J, Wang J, Yu X, Ling Z, Qu B, Pan L | Front Oncol | 2021
Stereotactic Body Radiotherapy for Recurrent or Oligometastatic Uterine Cervix Cancer: A Cooperative Study of the Korean Radiation Oncology Group (KROG 14-11)
Park HJ, Chang AR, Seo Y, Cho CK, Jang WI, Kim MS, Choi C | Anticancer Res | 2015
CyberKnife Stereotactic Ablative Radiotherapy for Recurrent or Oligometastatic Gynecological Cancers
Kataria T, Naga P, Banerjee S, Gupta D, Narang K, Tayal M, Bisht SS | South Asian J Cancer | 2021
Interested in conducting research with the CyberKnife® or Radixact® / TomoTherapy® Systems?
If you’re a member of Accuray Exchange (AEx), you can complete a collaboration application form here.
